Article
Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
International journal of medical sciences - 1 Jan 2011
Tan Shi, Zhang Ling, Zhong Xiao-Ming, Yang Zai-Lin, Zhao Liu-Yang, Gao Yu-Jie, Shao Hui-Yuan, Qin Feng-Xian, Chen Xian-Chun, Zhang Hui-Juan, Chen Hui, Wang Li
Abstract excerpt
Nucleophosmin (NPM1) gene mutations resulting in cytoplasmic delocalization of Nucleophosmin (NPMc+) are the most common genetic alteration in acute myeloid leukemia (AML). Here, we attempted to prepare monoclonal antibodies (mAbs) against NPM1 mutation A (NPM-mA) and investigated the mAbs' clinical utility in immunohistochemical detection of NPMc+AML. The pET-32a-NPM-mA vector with the whole open reading frame...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
